Omada Health, Inc.’s (NASDAQ:OMDA) Lock-Up Period To End on December 3rd

Omada Health’s (NASDAQ:OMDA) lock-up period is set to end on Wednesday, December 3rd. Omada Health had issued 7,900,000 shares in its IPO on June 6th. The total size of the offering was $150,100,000 based on an initial share price of $19.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

Wall Street Analysts Forecast Growth

OMDA has been the topic of a number of analyst reports. Baird R W upgraded shares of Omada Health to a “hold” rating in a research note on Friday, September 5th. Canaccord Genuity Group upped their price target on shares of Omada Health from $27.00 to $28.00 and gave the stock a “buy” rating in a report on Friday, August 8th. Weiss Ratings reiterated a “sell (d)” rating on shares of Omada Health in a research report on Wednesday, October 8th. Evercore ISI lifted their price objective on shares of Omada Health from $27.00 to $28.00 and gave the company an “outperform” rating in a research note on Friday, November 7th. Finally, BMO Capital Markets started coverage on Omada Health in a research note on Thursday, November 13th. They set an “outperform” rating and a $27.00 target price for the company. Eight analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $26.33.

Omada Health Stock Performance

OMDA opened at $18.13 on Wednesday. The firm has a 50 day moving average of $22.83. Omada Health has a 1-year low of $14.14 and a 1-year high of $28.40.

Institutional Trading of Omada Health

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Raymond James Financial Inc. bought a new stake in Omada Health during the 2nd quarter worth $32,000. Strs Ohio acquired a new stake in shares of Omada Health during the third quarter valued at about $38,000. Rakuten Investment Management Inc. bought a new stake in shares of Omada Health during the third quarter worth about $49,000. JPMorgan Chase & Co. acquired a new position in shares of Omada Health in the third quarter valued at approximately $82,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Omada Health in the 3rd quarter valued at approximately $95,000.

About Omada Health

Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.